| IMX-110 in Patients With Advanced Solid Tumors (NCT03382340) | Immix Biopharma Australia Pty Ltd | 2018-02-15 |
| Study of Pembrolizumab and Radiotherapy in Liver Cancer (NCT03316872) | University Health Network, Toronto | 2018-02-15 |
| Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC) (NCT03267498) | Sue Yom | 2018-02-14 |
| EMI-137 in Laparoscopic Colonic Resections (NCT03360461) | University of Leeds | 2018-02-14 |
| Pilot of Zinc Acetate to Improve Chronic Cough (NCT03135522) | Johns Hopkins University | 2018-02-14 |
| Toxicity & Pharmacokinetics of 2 & 3-weekly Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (NCT03343977) | Peng Wang, MD PhD | 2018-02-14 |
| Intraperitoneal Administration of Fosfomycin, Metronidazole and Molgramostim Versus Intravenous Antibiotics for Perforated Appendicitis (NCT03435900) | Herlev Hospital | 2018-02-14 |
| Lyophilized Fecal Transplant vs Lyophilized Fecal Filtrate in Recurrent C Diff Infection (NCT03353506) | Dina Kao | 2018-02-14 |
| Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer Patients (NCT03342417) | ExcellaBio LLC | 2018-02-14 |
| Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly (NCT03312231) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-02-14 |
| A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C (NCT03420768) | Bristol-Myers Squibb | 2018-02-14 |
| Pegcetacoplan (APL-2) in Neovascular AMD (NCT03465709) | Apellis Pharmaceuticals, Inc. | 2018-02-14 |
| Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Full-Thickness Skin Defects in Adults and Children (NCT03394612) | CUTISS AG | 2018-02-14 |
| Study to Determine if Pre- and Post- Operative TAP Catheters With Ropivacaine Versus Placebo Affects Anesthetic, Narcotic Dosing, and Pain Scores (NCT03149783) | University of Colorado, Denver | 2018-02-13 |
| Study of Ramucirumab, Trastuzumab and Paclitaxel in Patients With HER2-positive Recurrent/Metastatic Gastric Cancer (HER-RAM Study) (NCT04888663) | Yonsei University | 2018-02-13 |
| An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection (NCT03361956) | Janssen Sciences Ireland UC | 2018-02-13 |
| Trametinib in Patients With Advanced Neurofibromatosis Type 1 (NF1)-Mutant Non-small Cell Lung Cancer (NCT03232892) | University of California, San Francisco | 2018-02-13 |
| A Study to Evaluate a Potassium Normalization Treatment Regimen Including Sodium Zirconium Cyclosilicate (ZS) Among Patients With S-K ≥5.8 (NCT03337477) | AstraZeneca | 2018-02-13 |
| sEphB4-HSA in Treating Patients With Kaposi Sarcoma (NCT02799485) | AIDS Malignancy Consortium | 2018-02-13 |
| A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers (NCT03400332) | Bristol-Myers Squibb | 2018-02-12 |
| Anticoagulation Therapy After Splenectomy in Cirrhosis Patient (NCT04397289) | First Affiliated Hospital Xi'an Jiaotong University | 2018-02-12 |
| Study to Assess Efficacy and Safety of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral Infections (NCT03455491) | PHARMENTERPRISES LLC | 2018-02-12 |
| MMF for HIV Reservoir Reduction (NCT03262441) | Fred Hutchinson Cancer Center | 2018-02-12 |
| Adjuvant Immunotherapy After Salvage Surgery in Head and Neck Squamous Cell Carcinoma (NCT03406247) | Gustave Roussy, Cancer Campus, Grand Paris | 2018-02-12 |
| Relationship Between Plasma Concentration of Hydroxyprogesterone Caproate (17-OHPC) and Preterm Birth (NCT03292731) | Steve N. Caritis, MD | 2018-02-12 |
| Evaluation of Atezolizumab-Venetoclax-Obinutuzumab Combination in Relapse/Refractory Lymphomas (NCT03276468) | The Lymphoma Academic Research Organisation | 2018-02-12 |
| Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer (NCT03225547) | University of Chicago | 2018-02-12 |
| Topiramate for Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome (CSPN) (NCT02878798) | Virginia Commonwealth University | 2018-02-12 |
| Len/Dex/DLI in Relapsed Multiple Myeloma After Allogeneic Stem Cell Transplant (NCT03413800) | Ciusss de L'Est de l'Île de Montréal | 2018-02-12 |
| Safety and Efficacy of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Wild-type RAS and BRAF mCRC (NCT03405272) | Sinocelltech Ltd. | 2018-02-12 |
| Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant Epilepsy (NCT03373383) | UCB Biopharma S.P.R.L. | 2018-02-12 |
| Phase 2 Study of Duvelisib in Previously Treated Patients With Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (NCT03370185) | SecuraBio | 2018-02-12 |
| Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With Calcipotriene (NCT03448081) | Sienna Biopharmaceuticals | 2018-02-12 |
| Combined Therapy of Nivolumab and Adoptive T Cell Therapy in Metastatic Melanoma Patients (NCT03374839) | Nantes University Hospital | 2018-02-12 |
| Anti-viral Therapy in Alzheimer's Disease (NCT03282916) | Columbia University | 2018-02-12 |
| Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer (NCT03029403) | University Health Network, Toronto | 2018-02-12 |
| Pilot Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in Combination With GC4419 in Pancreatic Cancer (NCT03340974) | Galera Therapeutics, Inc. | 2018-02-12 |
| Evaluation of Skin Quality Improvement (NCT03097835) | Steve Yoelin M.D. Medical Associates, Inc. | 2018-02-12 |
| Study of Efficacy, Cycle Control, and Safety of a NES-E2 Contraceptive Vaginal Ring (NCT03432416) | Premier Research | 2018-02-12 |
| A Study of LJPC-501 in Pediatric Patients With Hypotension (NCT03431077) | La Jolla Pharmaceutical Company | 2018-02-11 |
| Effect of Metformin in Children With Type 1 Diabetes (NCT04879511) | Ain Shams University | 2018-02-10 |
| Specialized Food Plan Based on Individual Physiological Comprehensive Body Assessments Accompanied With Cellular Repair Therapy to Decrease Inflammation Cognitively Impaired Patients (NCT03630419) | Perseverance Research Center, LLC | 2018-02-10 |
| SHR-1210 in Combination With GEMOX in Patients With Advanced BTC (NCT03486678) | The First Affiliated Hospital with Nanjing Medical University | 2018-02-10 |
| Fecal Microbiota Transplantation for CRE/VRE (NCT03479710) | Chinese University of Hong Kong | 2018-02-10 |
| Probiotics as Adjuvant Therapy in the Treatment of Metastatic Colorectal Cancer (NCT03705442) | Marin Golčić | 2018-02-09 |
| Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU in Older Adults (NCT03437304) | Eurocine Vaccines AB | 2018-02-09 |
| A POC and Dose-Ranging Study of HTD1801 in PSC Patients (NCT03333928) | HighTide Biopharma Pty Ltd | 2018-02-09 |
| A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia (NCT03410875) | Memorial Sloan Kettering Cancer Center | 2018-02-09 |
| Postoperative subQ Pain Control for Spinal Fusion Surgery (NCT03476811) | University of Arizona | 2018-02-09 |
| Ascorbic Acid, Corticosteroids, and Thiamine in Sepsis (ACTS) Trial (NCT03389555) | Beth Israel Deaconess Medical Center | 2018-02-09 |
| Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence (NCT03396874) | University of Michigan | 2018-02-09 |
| Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma (NCT03223610) | National Cancer Institute (NCI) | 2018-02-09 |
| MGTA-456 in Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplantation (HSCT) (NCT03406962) | Magenta Therapeutics, Inc. | 2018-02-09 |
| Concurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain Metastases (NCT02974803) | Canadian Cancer Trials Group | 2018-02-09 |
| Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (NCT03147612) | M.D. Anderson Cancer Center | 2018-02-08 |
| SBRT With Immunotherapy in Early Stage Non-small Cell Lung Cancer: Tolerability and Lung Effects (NCT03383302) | Royal Marsden NHS Foundation Trust | 2018-02-08 |
| Low-Dose Danazol for the Treatment of Telomere Related Diseases (NCT03312400) | National Heart, Lung, and Blood Institute (NHLBI) | 2018-02-08 |
| A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream (NCT03462927) | MC2 Therapeutics | 2018-02-08 |
| Abraxane With Anti-PD1/PDL1 in Patients With Advanced Urothelial Cancer (NCT03240016) | University of Michigan Rogel Cancer Center | 2018-02-08 |
| Acute Pain Rate of Single Versus Two-visit Root Canal Treatment of Teeth With Necrotic Pulps (NCT04115904) | Universidad Autonoma de Baja California | 2018-02-08 |
| Ethosuximide to Treat IBS (NCT02973542) | University Hospital, Clermont-Ferrand | 2018-02-08 |
| Panobinostat, Carfilzomib, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma (NCT03256045) | University of Washington | 2018-02-08 |
| Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma (NCT03822936) | CNAO National Center of Oncological Hadrontherapy | 2018-02-08 |
| Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome (NCT03444038) | Neurocrine Biosciences | 2018-02-08 |
| Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer (NCT03201458) | National Cancer Institute (NCI) | 2018-02-08 |
| Fecal Microbiota Transplantation (FMT) for MDRO UTI (NCT03367910) | Washington University School of Medicine | 2018-02-08 |
| Clinical Trial of Sodium Nitrite for Out of Hospital Cardiac Arrest (NCT03452917) | University of Washington | 2018-02-08 |
| The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy (NCT03423849) | Zhiyong Yu | 2018-02-08 |
| Fexofenadine Use in Gastroesophageal Reflux Symptoms (NCT03425097) | Stanford University | 2018-02-07 |
| Irinotecan and Temozolomide for Ewing Sarcoma (NCT03359005) | Peking University People's Hospital | 2018-02-07 |
| GPPAD-POInT (Global Platform of Autoimmune Diabetes - Primary Oral Insulin Trial) (NCT03364868) | Technical University of Munich | 2018-02-07 |
| Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC) (NCT02973997) | Academic and Community Cancer Research United | 2018-02-07 |
| Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation (NCT03434730) | Memorial Sloan Kettering Cancer Center | 2018-02-07 |
| Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma (NCT03367715) | NYU Langone Health | 2018-02-07 |
| Red Rice Yeast in Low-density Lipoprotein (LDL) Lowering: an Efficacy Study (NCT03607383) | Saint-Joseph University | 2018-02-07 |
| Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG (NCT03879512) | Wuerzburg University Hospital | 2018-02-07 |
| Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation (NCT03373461) | Novartis Pharmaceuticals | 2018-02-07 |
| Avelumab With Valproic Acid in Virus-associated Cancer (NCT03357757) | AHS Cancer Control Alberta | 2018-02-07 |
| A Study of Second-line Treatment With Apatinib for Advanced Intrahepatic Cholangiocarcinoma (NCT03521219) | The First Affiliated Hospital of Zhengzhou University | 2018-02-07 |
| CHP-BV Followed by Consolidation With High-dose Therapy / ASCT as Frontline Treatment of Patients With EATL Type 1. (NCT03217643) | Imagine Institute | 2018-02-07 |
| Study of Pembrolizumab in Metastatic Biliary Tract Cancer as Second-line Treatment After Failing to at Least One Cytotoxic Chemotherapy Regimen: Integration of Genomic Analysis to Identify Predictive Molecular Subtypes (NCT03110328) | Samsung Medical Center | 2018-02-07 |
| Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery (NCT03384238) | George Poultsides | 2018-02-07 |
| PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPD (NCT03307512) | Dance Biopharm Inc. | 2018-02-06 |
| Study of EB-001 in Facial Scar Reduction (NCT03346902) | Bonti, Inc. | 2018-02-06 |
| Safety and Efficacy of DA-9805 for Parkinson's Disease (NCT03189563) | Dong-A ST Co., Ltd. | 2018-02-06 |
| Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery (NCT03008278) | National Cancer Institute (NCI) | 2018-02-06 |
| Nivolumab and Ipilimumab Treatment in Prostate Cancer With an Immunogenic Signature (NCT03061539) | University College, London | 2018-02-06 |
| Short-duration Selective Brain Cooling for Patients Undergoing Mechanical Thrombectomy (NCT03163459) | Capital Medical University | 2018-02-06 |
| Psoas Compartment Block (PCB) Versus L.A Infiltration and Remifentanil Infusion During EVAR (NCT03443518) | Dr. Erfan and Bagedo General Hospital | 2018-02-06 |
| Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma (NCT02341209) | Rochester General Hospital | 2018-02-06 |
| Olaparib Maintenance in Patients With MCRPC After Docetaxel Treatment Reaching Partial or Stable Response (IMANOL) (NCT03434158) | Spanish Oncology Genito-Urinary Group | 2018-02-06 |
| Safety and Efficacy of TJ301 IV in Participants With Active Ulcerative Colitis (NCT03235752) | I-Mab Biopharma HongKong Limited | 2018-02-06 |
| A Study to Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Participants Infected With Respiratory Syncytial Virus (NCT03379675) | Janssen Research & Development, LLC | 2018-02-06 |
| A Safety, PK and Efficacy Study of CC-92480 Monotherapy and in Combination With Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM) (NCT03374085) | Celgene | 2018-02-06 |
| Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Women (NCT03430037) | Mayo Clinic | 2018-02-06 |
| ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK (NCT03287271) | Michael McHale | 2018-02-06 |
| v4 Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-491 (NCT03447990) | Bristol-Myers Squibb | 2018-02-06 |
| Clinical Trial Assessing the Efficacy and Safety of BP1.4979 in Restless Legs Syndrome (NCT03345953) | Bioprojet | 2018-02-06 |
| Intraoperative Detection of Residual Cancer in Breast Cancer (NCT03321929) | Lumicell, Inc. | 2018-02-06 |
| A Pharmacokinetics Study of Favipiravir in Patients With Severe Influenza (NCT03394209) | Capital Medical University | 2018-02-06 |